Dr. Flavio Ramos Introduces Integrated Non-Surgical Obesity Treatment Model in Brazil
Industry: Healthcare
New clinical protocol combines advanced endoscopic bariatric techniques with injectable metabolic therapies for comprehensive obesity and metabolic care.
Rio de Janeiro, Brazil (PRUnderground) December 7th, 2025
Dr Flavio Mitidieri Ramos, Endoscopic Bariatric Specialist and Director of Endodiagnostic, is currently implementing a new non-surgical obesity treatment model that integrates modern endoscopic bariatric procedures with injectable metabolic therapies. This comprehensive approach has been attracting growing international interest for its ability to deliver consistent clinical outcomes without the risks traditionally associated with conventional bariatric surgery.
Developed as a personalized clinical protocol, this integrated model is designed to address both the anatomical and hormonal mechanisms involved in obesity within a single coordinated treatment strategy. By combining minimally invasive endoscopic techniques with modern injectable metabolic therapies—including GLP-1 receptor agonist–based treatments when clinically indicated—Dr. Ramos and his clinical team have observed total body weight reductions commonly ranging between 20% and 30%.
In addition to weight reduction, patients have demonstrated measurable improvements in key metabolic parameters, including glycemic control in type 2 diabetes, improvement in fatty liver disease markers, blood pressure regulation, and overall metabolic health. Individual results may vary based on clinical profile and adherence to treatment.
Unlike traditional bariatric surgery, endoscopic bariatric procedures require no external incisions, do not permanently alter gastrointestinal anatomy, and allow rapid recovery. Most patients are able to return to normal daily activities within a short period of time, making these techniques an increasingly preferred option in minimally invasive metabolic care.
Each patient undergoes a comprehensive metabolic, clinical, and behavioral assessment to define the most appropriate therapeutic combination under the principles of precision medicine and individualized care.
According to Dr. Ramos, the future of obesity treatment is no longer based on isolated interventions, but on the intelligent integration between advanced medical technology and metabolic science.
Dr. Flavio Mitidieri Ramos is a full member of the Brazilian Society of Digestive Endoscopy (SOBED), and his clinical work has become internationally recognized for integrating advanced endoscopic bariatric techniques with injectable metabolic therapies as part of a comprehensive, evidence-based approach to obesity and metabolic disease management.
This integrated treatment model is contributing to the growing international recognition of Brazil as a reference center for minimally invasive metabolic medicine and is helping reshape how obesity care is approached worldwide.
About Flavio M. Ramos, MD, MSc
Dr. Flavio M. Ramos, MD, MSc, is a Brazilian physician specialized in advanced digestive endoscopy and minimally invasive bariatric procedures. With extensive clinical, academic, and leadership experience, he is recognized for his contributions to the development and dissemination of innovative endoscopic techniques for obesity and gastrointestinal diseases. Dr. Ramos has played a key role in physician training, medical education, and the introduction of cutting-edge technologies in Brazil, positioning himself as an international reference in therapeutic endoscopy and metabolic treatment.
